Marshall Wace North America’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $18M | Buy |
113,146
+108,454
| +2,311% | +$17.3M | 0.08% | 249 |
|
|
2021
Q2 | $617K | Sell |
4,692
-172,020
| -97% | -$22.6M | ﹤0.01% | 1079 |
|
|
2021
Q1 | $22.8M | Sell |
176,712
-91,386
| -34% | -$11.8M | 0.09% | 231 |
|
|
2020
Q4 | $44.7M | Buy |
268,098
+56,684
| +27% | +$9.45M | 0.2% | 124 |
|
|
2020
Q3 | $32.6M | Buy |
211,414
+60,923
| +40% | +$9.4M | 0.21% | 125 |
|
|
2020
Q2 | $22.3M | Sell |
150,491
-31,020
| -17% | -$4.59M | 0.15% | 156 |
|
|
2020
Q1 | $20.4M | Sell |
181,511
-290,108
| -62% | -$32.7M | 0.15% | 153 |
|
|
2019
Q4 | $65.6M | Sell |
471,619
-356,893
| -43% | -$49.7M | 0.32% | 87 |
|
|
2019
Q3 | $79.8M | Sell |
828,512
-45,133
| -5% | -$4.35M | 0.45% | 66 |
|
|
2019
Q2 | $101M | Sell |
873,645
-287,831
| -25% | -$33.1M | 0.62% | 41 |
|
|
2019
Q1 | $137M | Buy |
1,161,476
+418,717
| +56% | +$49.3M | 0.97% | 22 |
|
|
2018
Q4 | $46.5M | Buy |
742,759
+39,672
| +6% | +$2.49M | 0.45% | 65 |
|
|
2018
Q3 | $49.8M | Buy |
703,087
+63,540
| +10% | +$4.5M | 0.34% | 80 |
|
|
2018
Q2 | $42.5M | Buy |
639,547
+66,676
| +12% | +$4.44M | 0.24% | 103 |
|
|
2018
Q1 | $37.5M | Buy |
572,871
+206,627
| +56% | +$13.5M | 0.19% | 127 |
|
|
2017
Q4 | $14.7M | Sell |
366,244
-88,241
| -19% | -$3.53M | 0.08% | 290 |
|
|
2017
Q3 | $16.4M | Buy |
454,485
+280,131
| +161% | +$10.1M | 0.1% | 254 |
|
|
2017
Q2 | $4.88M | Sell |
174,354
-5,001
| -3% | -$140K | 0.04% | 506 |
|
|
2017
Q1 | $5.02M | Buy |
+179,355
| New | +$5.02M | 0.04% | 393 |
|